Navigation Links
Dosing for RVX-208 Phase 1a Clinical Study Completed
Date:4/22/2008

Phase 1a study objectives were met

TSX Exchange Symbol: RVX

CALGARY, April 22 /PRNewswire-FirstCall/ - Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today that it has completed dosing of its Phase 1a safety, tolerability and pharmacokinetics study for its lead drug candidate, RVX-208, which addresses the dyslipidemia market. "Initial results from the emerging data are very good," declared Donald J. McCaffrey, President & CEO of Resverlogix. "As reported earlier this year the most remarkable results from this study continue to be the outstanding pharmacokinetics (drugability) of RVX-208. With these successful results in hand we are now planning for our Phase 1b/2a trial which, pending discussions and approval from the FDA, we expect to start later this year."

The primary objectives of the Phase 1a trial were to examine the safety, tolerability and pharmacokinetics of RVX-208. This study successfully met those objectives. In addition to the completed Phase 1a human clinical trial, RVX-208 has been the subject of 126 preclinical studies to date, comprising safety, toxicity, pharmacokinetics and pharmacology studies. The Company has selected the dosages to be used in the 28-day Phase 1b/2a study.

"We are very pleased with these promising results which indicate that RVX-208 is a safe and well tolerated drug," stated Dr. Jan Johansson, MD, PhD, Senior Vice President Medical Affairs of Resverlogix. "We are in the process of finalizing the tables, figures and legends for this past study." A review of the pharmacokinetic data was recently presented at the Arteriosclerosis, Thrombosis and Vascular Biology conference in Atlanta, GA.

About Cardiovascular Disease (CVD)

CVD can be generally defined as any abnormal condition characterized by dysfunction of the heart and blood vessels. CVD includes atherosclerosis (especially coronary heart disease which can lead to heart
'/>"/>

SOURCE Resverlogix Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Innocoll Announces Dosing of First Patient in a Second US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
2. Nventa completes enrollment and initial dosing of second cohort in Phase 1 HspE7 safety trial
3. Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
4. FDA Grants Resverlogix Approval to Commence a Phase 1 Clinical Trial for RVX-208
5. Reverse Cholesterol Transport by RVX-208 a Small Molecule for ApoA-I Production Increase Presented at American Heart Association Scientific Meeting
6. Immucor CEOs Italian Trial Moves Toward Second Phase
7. Medarex Reports Phase 1/2 Clinical Data of MDX-060 in Lymphoma at American Association for Cancer Research Meeting
8. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
9. AEterna Zentaris Completes Patient Recruitment for First Phase 3 Efficacy Trial with Cetrorelix in Benign Prostatic Hyperplasia
10. Spectrals EAA(TM) to be used in Phase III study for a sepsis anti-endotoxin therapy
11. ThromboGenics Completes Patient Enrolment of MITI IV Trial, a Phase II Study Evaluating the Safety and Preliminary Efficacy of Microplasmin in the Treatment of Acute Stroke
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...nce, December 2 NicOx S....has signed an agreement with,DSM for the commerci...tance,(or API, active pharmaceutical ingredient)....ct and the first compound in the,Cyclooxygenase-I...anti-inflammatory agents, which recently achieved ...
(Date:12/2/2008)... 2 Regado Biosciences, Inc., annou...e newly created position of Senior Vice President ... effective immediately. Ms. McDonald brings to Re...aceutical industry, with expertise heading busines...d marketing. She will report to David J. Mazzo, P...
(Date:12/2/2008)...RNewswire-FirstCall/ -- Cardiogenesis Corporation ...al products used in the treatment of patients suff...tion of veteran medical device executive and an ex...n as a member of the Company,s Board of Directors,... , Mr. Cohen, 49, has over 25 years of execu...
(Date:12/2/2008)...Earns an Innovation Point as a Stand-Alone Product... -- The National Geographic Society has used a one...e re-certified as a national leader in energy effi...chnology, manufactured by StrionAir of Louisville,...points for its LEED-EB 2.0* re-certification appli...
Breaking Biology Technology:NicOx Signs Agreement With DSM for the Commercial Manufacture of Naproxcinod Drug Substance 2NicOx Signs Agreement With DSM for the Commercial Manufacture of Naproxcinod Drug Substance 3NicOx Signs Agreement With DSM for the Commercial Manufacture of Naproxcinod Drug Substance 4Ellen McDonald Joins Regado Biosciences as Senior Vice President of Business Operations and Chief Business Officer 2Cardiogenesis Announces Addition of Raymond W. Cohen to Board of Directors 2Cardiogenesis Announces Addition of Raymond W. Cohen to Board of Directors 3National Geographic Uses Air Filtration in Bid To Be an Energy, Environmental Leader 2
... IT organizations rank high in national survey by ...ing United States businesses to ever-higher effici.... , ,No matter if it is enterprise resource planni...lined manufacturing software, IT is the vice that ...hat makes inclusion on the most recent Information...
...HICAGO Way back in the day, I had a problem. , ,...shed conservatory of music and I needed to finish ...delein College in Chicago that my two years of sig...ood for some transfer credits. , ,I then buckled ...few years of evenings and weekends. , ,Typically,...
...tilizing reliable market research on an ongoing ba...ul marketing campaign. Nevertheless, for many comp...ch and the costs of conducting marketing research ...can be expensive. Not knowing your customers needs...s quagmire is to go on gut instinct or apply someo...
... recently traveled to an event in Madison, Wis. th...echnology Network. It was designed to bring togeth...oncentration: Madison, Milwaukee and of course Chi... event (but the first to go on the road), the idea...n and women come together to meet each other for a...
Other Biology Technology:Wisconsins Business IT Innovators 2Avoid Trading Tech Relationships Like Pokmon Cards 2Avoid Trading Tech Relationships Like Pokmon Cards 3Talking Bout My Generation: The Evolution of Online Marketing Research 2Talking Bout My Generation: The Evolution of Online Marketing Research 3Mike Rosen Reviews - eXtreme Networking in Madison 2Mike Rosen Reviews - eXtreme Networking in Madison 3
(Date:12/2/2008)...gers, The State University of New Jersey, has rece...t Wood Johnson Foundation to establish the Institu.... Cook Campus. , Rutgers President Richard L. McC...w institute during his Annual Address to the Unive...rmick made it clear the new institute would focus ...
(Date:12/2/2008)...le in German . , , Sometimes physicists r...ientists at the Max Planck Institute for Metals Re...do School of Mines have constructed micromachines ...ships into a bottle where the masts and rigging of...he bottle. In the same way, the scientists link th...
(Date:12/2/2008).... 2, 2008 Presbycusis, or age-related hearing los...o, why do some people lose their hearing as they g...p? , The answer may be in a study released onl...ance access is available online at http://hmg.oxf...the first ever and largest genome-wide association...
(Date:12/1/2008)...covering the meaning of a rare mineral that can be...sity geologist Tim Lowenstein is helping climatolo...ably in for over the next century or two as global...ely, to change life as we know it. , "I think t...t hundred years or so, and that many species will ...
Breaking Biology News(10 mins):Rutgers receives US$10 million to establish Institute for Food, Nutrition and Health 2Ship-in-a-bottle kit on a microchip 2Ship-in-a-bottle kit on a microchip 3House Ear Institute, TGen and Belgian researchers identify gene in age-related hearing loss 2Foretelling a major meltdown 2Foretelling a major meltdown 3China Nepstar Chain Drugstore to Implement SAP ERP Solution to Optimize Management and Cost Controls and Enhance Operating Efficiencies 13371 1China Nepstar Chain Drugstore to Implement SAP ERP Solution to Optimize Management and Cost Controls and Enhance Operating Efficiencies 13371 2China Nepstar Chain Drugstore to Implement SAP ERP Solution to Optimize Management and Cost Controls and Enhance Operating Efficiencies 13371 3China Biologic Products Commences Trading on OTC Bulletin Board 3686 1China Biologic Products Commences Trading on OTC Bulletin Board 3686 2NuVasive Prices 24200 Million Convertible Senior Notes Due 2013 13369 1NuVasive Prices 24200 Million Convertible Senior Notes Due 2013 13369 2NuVasive Prices 24200 Million Convertible Senior Notes Due 2013 13369 3Elsevier Launches Publishing Ethics Resource Kit 13368 1Elsevier Launches Publishing Ethics Resource Kit 13368 2
... 5 in an advanced, online edition of the Proceedin... significant enhancement of the treatment of metas...owed the new hybrid compound remained in circulati...rug was cleared in a matter of minutes. , "Althou..., these new findings could have broad application ...
...ng effect on some of the world,s finest coral reef...rt to show the long-term impact of sea temperature... sections of coral reefs and much of the marine li... international team of researchers, who surveyed 2...fs in the inner islands of the Seychelles in 1994 ...
...e University at Buffalo has received a $1.98 milli...estigate the potential of bone marrow-derived adul...n known as hibernating myocardium. , Hibernating m... have experienced reduced blood flow over an exten...es adapt to this deprivation by down-regulating me...
... subject their subordinates to escalating aggressi...verly stressed and as a result infertile, a new st... the latter half of her pregnancy, the dominant fe...inate females from the group for an average of thr...pically those with whom reproductive conflict is m...
Other Biology News:Researchers unveil strategy for creating actively-programmed anti-cancer molecules 2Researchers unveil strategy for creating actively-programmed anti-cancer molecules 3Global warming may have damaged coral reefs forever 2Adult stem cell research at UB targets damaged hearts 2Dominant meerkats render rivals infertile 2
NPT1 (M-19)
XA7 B6
Total Proteins from over 50 different human Alzheimer, Diabetic, Liver Cirrhosis, and Lupus diseased tissues are available.
...Wolf valve has the highest performance characteris...able on the market. This VSO valve offers silent o...ce, and ensures maximum accuracy., Achieves rapi...and patient comfort. , Maintains ideal flow throug...
Biology Products: